1.Mineralization-inducing potentials of calcium silicate-based pulp capping materials in human dental pulp cells
Yeungnam University Journal of Medicine 2020;37(3):217-225
Background:
To provide a long-term bacterial seal through the formation of reparative dentin bridge, calcium silicate-based pulp capping materials have been used at sites of pulpal exposure. The aim of this study was to evaluate the mineralization-inducing potentials of calcium silicate-based pulp capping materials (ProRoot MTA [PR], Biodentine [BD], and TheraCal LC [TC]) in human dental pulp cells (HDPCs).
Methods:
Specimens of test materials were placed in deionized water for various incubation times to measure the pH variation and the concentration of calcium released. The morphology of HDPCs cultured on the specimens was examined using a confocal laser scanning microscope (CLSM). Alizarin red S staining and alkaline phosphatase assays were used to evaluate mineralization-inducing potentials of the capping materials.
Results:
BD showed the highest calcium release in all test periods, followed by PR and TC. (p<0.05). All experimental groups showed high alkalinity after 1 day, except at 14 days. BD showed the highest cell viability compared with PR and TC after 1 and 3 days, while TC showed the lowest value (p<0.05). The CLSM analysis showed that cells were well adhered and expressed actin filaments for all pulp capping materials. Mineralization by PR and BD groups was higher than that by TC group based on alizarin red S staining. BD showed significantly higher alkaline phosphatase activity than PR and TC, while TC showed the lowest value (p<0.05).
Conclusion
Within the limitations of the in vitro study, BD had higher mineralization-inducing potential than PR and TC.
2.Does the Obesity Paradox Exist in Cognitive Function?: Evidence from the Korean Longitudinal Study of Ageing, 2006–2016
Kyung Sik KANG ; Yongjae LEE ; Sohee PARK ; Heejin KIMM ; Woojin CHUNG
Health Policy and Management 2020;30(4):493-504
Background:
There have been many studies on the associations between body mass index (BMI) and cognitive function. However, no study has ever compared the associations across the methods of categorizing BMI. In this study, we aimed to fill the gap in the previous studies and examine whether the obesity paradox is valid in the risk of cognitive function.
Methods:
Of the 10,254 people aged 45 and older from the Korean Longitudinal Study of Ageing from 2006 to 2016, 8,970 people were finalized as the study population. The dependent variable was whether a person has a normal cognitive function or not, and the independent variables of interest were BMI categorized by the World Health Organization Western Pacific Regional Office (WHO-WPRO) method, the WHO method, and a 10-group method. Covariates included sociodemographic factors, health behavior factors, and health status factors. A generalized linear mixed model analysis with a logit link was used.
Results:
In the adjusted model with all covariates, first, in the case of BMI categories of the WHO-WPRO method, underweight (odds ratio [OR], 1.16; 95% confidence interval [CI], 1.15–1.17), overweight (OR, 1.36; 95% CI, 1.35–1.36), and obese (OR, 1.34; 95% CI, 1.33–1.34) groups were more likely to have a normal cognitive function than a normal-weight group. Next, in the case of BMI categories of the WHO method, compared to a normal-weight group, underweight (OR, 1.15; 95% CI, 1.14–1.16) and overweight (OR, 1.06; 95% CI, 1.06–1.07) groups were more likely to have a normal cognitive function; however, obese (OR, 0.62; 95% CI, 0.61–0.63) group was less likely to have it. Lastly, in the case of the 10-group method, as BMI increased, the likelihood to have a normal cognitive function changed like a wave, reaching a global top at group-7 (26.5 kg/㎡ ≤ BMI <28.0 kg/㎡ ).
Conclusion
The associations between BMI and cognitive function differed according to how BMI was categorized among people aged 45 and older in Korea, which suggests that cognitive function may be positively associated with BMI in some categories of BMI but negatively in its other categories. Health policies to reduce cognitive impairment need to consider this association between BMI and cognitive function.
3.Current aspects and prospects of glass ionomer cements for clinical dentistry
Yeungnam University Journal of Medicine 2020;37(3):169-178
Glass ionomer cement (GIC) is a tailor-made material that is used as a filling material in dentistry. GIC is cured by an acid-base reaction consisting of a glass filler and ionic polymers. When the glass filler and ionic polymers are mixed, ionic bonds of the material itself are formed. In addition, the extra polymer anion reacts with calcium in enamel or dentin to increase adhesion to the tooth tissue. GICs are widely used as adhesives for artificial crowns or orthodontic brackets, and are also used as tooth repair material, cavity liner, and filling materials. In this review, the current status of GIC research and development and its prospects for the future have been discussed in detail.
4.Identification and Application of Biomarkers in Molecular and Genomic Epidemiologic Research.
Kyoung Mu LEE ; Sohee HAN ; Woong Yang PARK ; Daehee KANG
Journal of Preventive Medicine and Public Health 2009;42(6):349-355
Biomarkers are characteristic biological properties that can be detected and measured in a variety of biological matrices in the human body, including the blood and tissue, to give an indication of whether there is a threat of disease, if a disease already exists, or how such a disease may develop in an individual case. Along the continuum from exposure to clinical disease and progression, exposure, internal dose, biologically effective dose, early biological effect, altered structure and/or function, clinical disease, and disease progression can potentially be observed and quantified using biomarkers. While the traditional discovery of biomarkers has been a slow process, the advent of molecular and genomic medicine has resulted in explosive growth in the discovery of new biomarkers. In this review, issues in evaluating biomarkers will be discussed and the biomarkers of environmental exposure, early biologic effect, and susceptibility identified and validated in epidemiological studies will be summarized. The spectrum of genomic approaches currently used to identify and apply biomarkers and strategies to validate genomic biomarkers will also be discussed.
Disease Progression
;
Environmental Exposure
;
*Epidemiologic Studies
;
*Genetic Markers
;
Humans
;
Molecular Epidemiology/*methods
;
Neoplasms/epidemiology
;
Republic of Korea/epidemiology
5.A Case of Nocardia farcinica Pneumonia and Mediastinitis in an Immunocompetent Patient.
Jinyoung KIM ; Minkyu KANG ; Juri KIM ; Sohee JUNG ; Junhung PARK ; Dongkyu LEE ; Heejung YOON
Tuberculosis and Respiratory Diseases 2016;79(2):101-103
Nocardia species are aerobic, gram-positive pathogens found worldwide in soil. Nocardia is considered an opportunistic pathogen, and its infection mostly occurs in immunocompromised patients. We report a case of Nocardia farcinica induced mediastinitis and pneumonia that occurred in a 64-year-old male patient who had no significant medical history except for hypertension. He visited another hospital with a complaint of dyspnea and left chest wall pain. The symptoms arose 7 days ago without any trauma and they worsened. A mediastinal mass was found on computed tomography scan. After being transferred to our hospital for further evaluation, he was diagnosed with mediastinitis and pneumonia. As N. farcinica was found to be the causative organism by 16S rRNA sequencing, proper antibiotic therapy including trimethoprim/sulfamethoxazole was initiated immediately. After this, the patient improved and he was discharged. If an infection has a disseminating course, nocardiosis cannot be excluded even in immunocompetent patients. Once the diagnosis is established, prompt antibiotic therapy should be performed based on the severity.
Diagnosis
;
Dyspnea
;
Humans
;
Hypertension
;
Immunocompromised Host
;
Male
;
Mediastinitis*
;
Middle Aged
;
Nocardia Infections
;
Nocardia*
;
Pneumonia*
;
Soil
;
Thoracic Wall
6.Serum Albumin Levels: A Simple Answer to a Complex Problem? Are We on the Right Track of Assessing Metabolic Syndrome?.
Endocrinology and Metabolism 2013;28(1):17-19
No abstract available.
Serum Albumin
;
Track and Field
7.Effects of Benzo(a)pyrene on the Expression of Heat Shock Proteins, Pro-inflammatory Cytokines and Antioxidant Enzymes in Hepatic Tumors Induced by Rat Hepatoma N1-S1 Cells.
Zhi ZHENG ; So Young PARK ; Min LEE ; Sohee PHARK ; Nam Hee WON ; Hyung Sik KANG ; Donggeun SUL
Journal of Korean Medical Science 2011;26(2):222-230
Benzo(a)pyrene (BaP) is a polycyclic aromatic hydrocarbon (PAH) that is easily introduced to humans via consumption of grilled or smoked meat. BaP causes harmful oxidative effects on cell development, growth and survival through an increase in membrane lipid peroxidation, oxidative DNA damage and mutagenesis. Therefore, the present study was conducted to evaluate the synergistic effects of BaP on oxidative stress in hepatic tumors. In this study, we established a hepatic tumor model by injecting rat hepatoma N1-S1 cells into healthy rats. Changes in the abundance of heat shock proteins (HSPs), antioxidant enzymes and pro-inflammatory cytokines were then investigated by western blot analysis. In addition, we examined changes in oxidative stress levels. Injection of N1-S1 cells or concomitant injection of BaP and N1-S1 cells resulted in the formation of hepatic tumors at the injection site. Evaluation of rat plasma reveals that hepatic tumors induced by BaP and N1-S1 cells expresses higher levels of Hsp27, superoxide dismutase (SOD), and tumor necrosis factor-alpha (TNF-alpha) when compared to those induced by N1-S1 cells only. The collective results of this study suggest that BaP exerts synergistic effects on the expression of HSP, cytokines and antioxidant enzymes in hepatic tumors induced by rat hepatoma N1-S1 cells.
Animals
;
Antioxidants/*metabolism
;
Benzo(a)pyrene/*pharmacology
;
Carcinoma, Hepatocellular/metabolism/pathology
;
Cell Line, Tumor/*drug effects
;
Cytokines/*metabolism
;
Heat-Shock Proteins/*metabolism
;
Humans
;
Liver Neoplasms/*enzymology/*metabolism/pathology
;
Male
;
Neoplasms, Experimental/metabolism/pathology
;
Oxidative Stress/drug effects
;
Rats
;
Rats, Sprague-Dawley
8.Therapeutic Outcomes of Vagus Nerve Stimulation in Intractable Childhood Epilepsy.
Jeong Tae KIM ; Yang Hyun KIM ; Hoon Chul KANG ; Sohee EUN ; Yong Soon HWANG ; Dong Suk KIM ; Heung Dong KIM
Journal of the Korean Child Neurology Society 2004;12(2):132-143
PURPOSE: VNS has been used as a adjunctive treatment modality in medically intractable epilepsy patients since 1988, and is presently considered a safe and effective mode of treatment. However, its safety and efficacy in pediatric epilepsy patients have not been as well- studied. We the authors have experienced 12 pediatric patients who received VNS implantation, and evaluated the safety and efficacy of the procedure in the pediatric age group. METHODS: 12 patients who received VNS implantation in Yonsei University Medical Center and Sang-gye Paik Hospital Epilepsy Center from June 1999 to April 2004 have been evaluated for clinical symptoms, presence of reduction in seizure frequency, EEG changes and side-effects after VNS implantation. Datas were analyzed retrospectively through review of clinical records, with emphasis on evaluation of effectiveness and safety of the treatment. RESULTS: Mean age of the patients at the time of VNS implantation were 9 years 9 months (+/-60.5 months)(2 year 9 months-17 years 10 months). Mean duration of follow-up was 21.6 months (+/-23.3 months). Five patients out of twelve could be followed-up for more than 12 months. Nine out of twelve patients possessed Lennox-Gastaut syndrome, two were diagnosed as partial seizure with secondary generalization, and one patient had gelastic seizure caused by hypothalamic harmatoma. Eight patients showed more than 50% reduction in seizure frequency compared with baseline 3 months after the implantation, with two patients exhibiting complete seizure ablation. One patient showed a 25% decrease in seizure frequency, and VNS was ineffective in three patients. Among the patients with more than 50% reduction of seizures, two patients respectively showed a 75% and 90% decrease in seizure frequency at 12 months and 24 months post-operatively. One case of hoarseness, one case of dyspnea during sleep, one case of post-operative wound infection and one case of generator malfunction were noted after VNS, but most of these adverse effects improved through manipulation of output current. Wound infection necessitated surgical revision and generator failure required surgical removal of the device. EEG patterns of the two patients with complete seizure ablation exhibited marked improvement of background rhythms and reduction of epileptogenic discharges, but others did not show any significant improvement in their EEG. CONCLUSION: This study showed significant improvement in seizure frequencies among medically intractable pediatric epilepsy patients after VNS, and most of its adverse effects could be controlled without discontinuation of treatment. Therefore, we believe that VNS is a safe and effective treatment modality in pediatric patients with intractable epilepsy, and merits wider implementation for medically intractable epileptic children in the future.
Academic Medical Centers
;
Child
;
Dyspnea
;
Electroencephalography
;
Epilepsy*
;
Follow-Up Studies
;
Generalization (Psychology)
;
Hoarseness
;
Humans
;
Reoperation
;
Retrospective Studies
;
Seizures
;
Vagus Nerve Stimulation*
;
Vagus Nerve*
;
Wound Infection
9.Refractory Graves' Disease Successfully Cured by Adjunctive Cholestyramine and Subsequent Total Thyroidectomy.
Yeoree YANG ; Seawon HWANG ; Minji KIM ; Yejee LIM ; Min Hee KIM ; Sohee LEE ; Dong Jun LIM ; Moo Il KANG ; Bong Yun CHA
Endocrinology and Metabolism 2015;30(4):620-625
The three major forms of treatment for Graves thyrotoxicosis are antithyroid drugs, radioactive iodine therapy and thyroidectomy. Surgery is the definitive treatment for Graves thyrotoxicosis that is generally recommended when other treatments have failed or are contraindicated. Generally, thyrotoxic patients should be euthyroid before surgery to minimize potential complications which usually requires preoperative management with thionamides or inorganic iodine. But several cases of refractory Graves' disease have shown resistance to conventional treatment. Here we report a 40-year-old female patient with Graves' disease who complained of thyrotoxic symptoms for 7 months. Her thyroid function test and thyroid autoantibody profiles were consistent with Graves' disease. One kind of thionamides and beta-blocker were started to control her disease. However, she was resistant to nearly all conventional medical therapies, including beta-blockers, inorganic iodine, and two thionamides. She experienced hepatotoxicity from the thionamides. What was worse is her past history of serious allergic reaction to corticosteroids, which are often used to help control symptoms. A 2-week regimen of high-dose cholestyramine improved her uncontrolled thyrotoxicosis and subsequent thyroidectomy was successfully performed. In conclusion, cholestyramine could be administered as an effective and safe adjunctive agent for preoperative preparation in patients with severe hyperthyroid Graves's disease that is resistant to conventional therapies.
Adrenal Cortex Hormones
;
Adult
;
Antithyroid Agents
;
Cholestyramine Resin*
;
Drug Resistance
;
Female
;
Glycogen Storage Disease Type VI
;
Graves Disease*
;
Humans
;
Hypersensitivity
;
Iodine
;
Thyroid Function Tests
;
Thyroid Gland
;
Thyroidectomy*
;
Thyrotoxicosis
10.Medullary thyroid carcinoma: a 30-year experience at one institution in Korea.
Cho Rok LEE ; Sohee LEE ; Haiyoung SON ; Eunjeong BAN ; Sang Wook KANG ; Jandee LEE ; Jong Ju JEONG ; Kee Hyun NAM ; Woong Youn CHUNG ; Cheong Soo PARK
Annals of Surgical Treatment and Research 2016;91(6):278-287
PURPOSE: The objective of this study was to review the clinical outcome and prognosis of patients with sporadic and hereditary medullary thyroid cancer (MTC) who were treated at a single tertiary hospital in Korea. METHODS: We retrospectively reviewed the case files of 85 patients treated from August 1982 to February 2012. RESULTS: In all, 65 patients (76.5%) had sporadic MTC and 20 patients (23.5%) had hereditary MTC. Patients in the sporadic group were older than in the hereditary group (P < 0.001). However, the hereditary group had more tumor multiplicity (P < 0.001) and bilaterality (P < 0.001). Neither survival rate was significantly different between the sporadic and hereditary groups (P = 0.775 and P = 0.866). By multivariate analysis, distant metastasis was a significant prognostic factor for overall and progression-free survival. CONCLUSION: In general, patients with MTC have favorable outcomes. Distant metastasis appears to be the strongest predictor of overall and progression-free survival.
Disease-Free Survival
;
Humans
;
Korea*
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Prognosis
;
Retrospective Studies
;
Survival Rate
;
Tertiary Care Centers
;
Thyroid Gland*
;
Thyroid Neoplasms*

Result Analysis
Print
Save
E-mail